Patents by Inventor Hans Dieplinger

Hans Dieplinger has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for Diagnosing Preeclampsia
    Publication number: 20140127703
    Abstract: Described is a method for in vitro diagnosing whether a pregnant woman has a risk for developing preeclampsia (PE) comprising the steps of determining the afamin content of the pregnant woman in a blood sample or a blood-derived sample, urine, amniotic and cerebrospinal fluid; or determining the content of afamin m-RNA in a liver tissue sample; and comparing the afamin content determined in the sample with a reference value.
    Type: Application
    Filed: June 28, 2012
    Publication date: May 8, 2014
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Hannes Buchner, Christian Wadsack, Ludwig Wildt, Benjamin Dieplinger
  • Method for diagnosing the metabolic syndrome (MS)
    Patent number: 8137922
    Abstract: The present invention discloses a method for diagnosing the metabolic syndrome by determination of the afamin content in a sample of a body fluid or a tissue sample, wherein the metabolic syndrome is diagnosed if the afamin content in the sample is increased compared to the afamin content in a sample from a person not having the metabolic syndrome.
    Type: Grant
    Filed: September 4, 2008
    Date of Patent: March 20, 2012
    Assignee: Hans Dieplinger
    Inventors: Hans Dieplinger, Florian Kronenberg, Johann Willeit, Stefan Kiechl, Wolfgang Engel
  • Method for diagnosing tumors
    Patent number: 8129129
    Abstract: The present invention describes a method for diagnosing tumors of the reproductive organs which is characterized by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumor is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumor of the reproductive organs.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: March 6, 2012
    Assignee: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Use of Afamin for Treating Fertility Disorders
    Publication number: 20110179509
    Abstract: The invention relates to the use of afamin for the manufacture of a pharmaceutical preparation for the prevention or treatment of fertility disorders.
    Type: Application
    Filed: October 1, 2009
    Publication date: July 21, 2011
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Wolfgang Engel, Georg Wietzorrek
  • Method for Diagnosing the Metabolic Syndrome (MS)
    Publication number: 20100260771
    Abstract: The present invention discloses a method for diagnosing the metabolic syndrome by determination of the afamin content in a sample of a body fluid or a tissue sample, wherein the metabolic syndrome is diagnosed if the afamin content in the sample is increased compared to the afamin content in a sample from a person not having the metabolic syndrome.
    Type: Application
    Filed: September 4, 2008
    Publication date: October 14, 2010
    Inventors: Hans Dieplinger, Florian Kronenberg, Johann Willeit, Stefan Kiechl, Wolfgang Engel
  • Method for Diagnosing Tumors
    Publication number: 20100196924
    Abstract: The present invention describes a method for diagnosing tumors of the reproductive organs which is characterised by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumour is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumour of the reproductive organs.
    Type: Application
    Filed: March 12, 2010
    Publication date: August 5, 2010
    Inventor: Hans Dieplinger
  • Method for diagnosing tumors
    Patent number: 7767406
    Abstract: The present invention describes a method for diagnosing tumours of the reproductive organs which is characterised by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumour is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumour of the reproductive organs.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: August 3, 2010
    Assignee: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Method for Diagnosing Tumors by Measuring the Level of Apolipoprotein A-IV
    Publication number: 20100136583
    Abstract: Method for diagnosing a tumor in an individual comprising the following steps: —measuring the amount of apolipoprotein A-IV (ApoA-IV) in a body fluid sample or tissue sample of an individual, —comparing the measured amount of ApoA-IV in said sample with a reference value, wherein the reference value is the ApoA-IV content in a sample derived from an individual without a tumor, and —diagnosing a tumor if the ApoA-IV content in the sample is decreased compared to the reference value.
    Type: Application
    Filed: August 8, 2006
    Publication date: June 3, 2010
    Applicant: VITATEQ BIOTECHNOLOGY GMBH
    Inventors: Hans Dieplinger, Florian Kronenberg
  • Method For Diagnosing Tumors
    Publication number: 20080166737
    Abstract: The present invention describes a method for diagnosing tumours of the reproductive organs which is characterised by determination of the afamin content in a sample of a body fluid or in a tissue sample, wherein a tumour is diagnosed if the afamin content in the sample is decreased compared to the afamin content in a sample from a person without a tumour of the reproductive organs.
    Type: Application
    Filed: January 31, 2006
    Publication date: July 10, 2008
    Applicant: Vitateq Biotechnology GmbH
    Inventor: Hans Dieplinger
  • Afamin-containing compositions and methods of use
    Patent number: 7365049
    Abstract: The use of Afamin, in particular in combination with vitamin E is described for producing a preparation for the treatment of oxidative stress.
    Type: Grant
    Filed: April 30, 2002
    Date of Patent: April 29, 2008
    Assignee: Vitateg Biotechnology GmbH
    Inventors: Michael Becker-Andre, Hans Dieplinger, Charlotte Teunissen, Lidija Jerkovic
  • Afamin-containing compositions methods of use
    Publication number: 20040235718
    Abstract: The use of Afamin, in particular in combination with vitamin E is described for producing a preparation for the treatment of oxidative stress.
    Type: Application
    Filed: June 21, 2004
    Publication date: November 25, 2004
    Inventors: Michael Becker-Andre, Hans Dieplinger, Charlotte Teunissen, Lidija Jerkovic
  • Method for determining the fertility of mammals, especially humans
    Patent number: 6762033
    Abstract: Disclosed is a method for determining the fertility of mammals, in particular of humans, wherein a body or organ fluid is taken from a mammal, the afamin content is determined in this body or organ fluid, and the determined afamin content is compared with a reference value so as to determine the fertility, the use of afamin for determining the fertility of mammals, as well as a kit for carrying out this method.
    Type: Grant
    Filed: December 21, 2001
    Date of Patent: July 13, 2004
    Assignee: Vitateq Biotechnology GmbH
    Inventors: Karl Oskar Illmensee, Hans Dieplinger
  • Method for determining the fertility of mammals, especially of humans
    Publication number: 20020137100
    Abstract: Disclosed is a method for determining the fertility of mammals, in particular of humans, wherein
    Type: Application
    Filed: March 22, 2002
    Publication date: September 26, 2002
    Applicant: Vitateq Biotechnology GMBH
    Inventors: Karl Oskar Illmensee, Hans Dieplinger
  • Method for determining the fertility of mammals, especially humans
    Publication number: 20020055182
    Abstract: Disclosed is a method for determining the fertility of mammals, in particular of humans, wherein
    Type: Application
    Filed: December 21, 2001
    Publication date: May 9, 2002
    Applicant: Vitateq Biotecnology Biotechnology GMBH
    Inventors: Karl Oskar Illmensee, Hans Dieplinger